Lidocaine Hydrochloride and Hydrocortisone Acetate
NDC 13925-164, Lidocaine Hydrochloride and Hydrocortisone Acetate, gel, from Seton Pharmaceuticals.
- Product NDC
- 13925-164
- Status
- Listed
- Labeler
- Seton Pharmaceuticals
- Dosage form
- GEL
- Route
- RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13925-164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIDOCAINE HYDROCHLORIDE30 mg/g
- HYDROCORTISONE ACETATE25 mg/g
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13925-164-20 | 13925016420 | 20 TUBE in 1 KIT (13925-164-20) / 7 g in 1 TUBE (13925-164-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fd6343a9-15a6-4894-b51f-122e4d6dbe79
Use it
Look up 13925-164 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13925-164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13925-164. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.